entertainment -WSS

entertainment

author：hotspot 2025-10-01 23:31:38 - browse：15

Sammy Kimball for STAT

Can biotech startups survive a downturn? Is Covid-19 a good business? And when did ophthalmology get so dramatic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss what some recent layoffs and a reverse merger mean for biotech in 2023. We’ll also discuss the latest news in the life sciences, including a dramatic saga in ocular medicine, the volatile business of Covid-19, and some major milestones in gene therapy.

For more on what we cover, here’s the news on Celsius Therapeutics; here’s more on EQRx; here’s the latest on Apellis Pharmaceuticals; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Emergency workers more likely to restrain Black patients: study

explore

WSS

Intarcia’s device

Why are Kaiser Permanente staff considering a strike?

Second xenotransplant done with gene

STAT Virtual Event: Putting AI to the Test

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Why failed clinical trials don’t always spell doom for a new drug

focus

entertainment

Wikipedia

DIEP, the 'gold standard' of breast reconstruction, is under threat

Man killed during FBI raid in connection with threats against Biden, other officials

As demand for Covid shots wanes, Moderna seeks its next success

Drastic changes should bring profitability, startup health insurers say

DIEP, the 'gold standard' of breast reconstruction, is under threat

Intarcia’s device

Peter Hotez and the public health issue of online harassment

How Vertex's cystic fibrosis drug is changing patients' lives

At least 13 dead in Texas as scorching temps continue

Drastic changes should bring profitability, startup health insurers say

knowledge

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Why failed clinical trials don’t always spell doom for a new drug

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Why are Kaiser Permanente staff considering a strike?

explore

Wikipedia

Wikipedia

hotspot